Your browser doesn't support javascript.
loading
The impact of forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
Dirks, Marlou L; Jameson, Tom S O; Andrews, Rob C; Dunlop, Mandy V; Abdelrahman, Doaa R; Murton, Andrew J; Wall, Benjamin T; Stephens, Francis B.
Afiliación
  • Dirks ML; Department of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, United Kingdom.
  • Jameson TSO; Human and Animal Physiology, Wageningen University, Wageningen, The Netherlands.
  • Andrews RC; Department of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, United Kingdom.
  • Dunlop MV; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
  • Abdelrahman DR; National Institute for Health and Care Research Exeter Biomedical Research Centre, Exeter, United Kingdom.
  • Murton AJ; Department of Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, United Kingdom.
  • Wall BT; Department of Surgery, University of Texas Medical Branch, Galveston, Texas, United States.
  • Stephens FB; Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas, United States.
Am J Physiol Endocrinol Metab ; 326(3): E277-E289, 2024 Mar 01.
Article en En | MEDLINE | ID: mdl-38231001
ABSTRACT
Although the mechanisms underpinning short-term muscle disuse atrophy and associated insulin resistance remain to be elucidated, perturbed lipid metabolism might be involved. Our aim was to determine the impact of acipimox administration [i.e., pharmacologically lowering circulating nonesterified fatty acid (NEFA) availability] on muscle amino acid metabolism and insulin sensitivity during short-term disuse. Eighteen healthy individuals (age 22 ± 1 years; body mass index 24.0 ± 0.6 kg·m-2) underwent 2 days forearm immobilization with placebo (PLA; n = 9) or acipimox (ACI; 250 mg Olbetam; n = 9) ingestion four times daily. Before and after immobilization, whole body glucose disposal rate (GDR), forearm glucose uptake (FGU; i.e., muscle insulin sensitivity), and amino acid kinetics were measured under fasting and hyperinsulinemic-hyperaminoacidemic-euglycemic clamp conditions using forearm balance and l-[ring-2H5]-phenylalanine infusions. Immobilization did not affect GDR but decreased insulin-stimulated FGU in both groups, more so in ACI (from 53 ± 8 to 12 ± 5 µmol·min-1) than PLA (from 52 ± 8 to 38 ± 13 µmol·min-1; P < 0.05). In ACI only, and in contrast to our hypothesis, fasting arterialized NEFA concentrations were elevated to 1.3 ± 0.1 mmol·L-1 postimmobilization (P < 0.05), and fasting forearm NEFA balance increased approximately fourfold (P = 0.10). Forearm phenylalanine net balance decreased following immobilization (P < 0.10), driven by an increased rate of appearance [from 32 ± 5 (fasting) and 21 ± 4 (clamp) preimmobilization to 53 ± 8 and 31 ± 4 postimmobilization; P < 0.05] while the rate of disappearance was unaffected by disuse or acipimox. Disuse-induced insulin resistance is accompanied by early signs of negative net muscle amino acid balance, which is driven by accelerated muscle amino acid efflux. Acutely elevated NEFA availability worsened muscle insulin resistance without affecting amino acid kinetics, suggesting increased muscle NEFA uptake may contribute to inactivity-induced insulin resistance but does not cause anabolic resistance.NEW & NOTEWORTHY We demonstrate that 2 days of forearm cast immobilization in healthy young volunteers leads to the rapid development of insulin resistance, which is accompanied by accelerated muscle amino acid efflux in the absence of impaired muscle amino acid uptake. Acutely elevated fasting nonesterified fatty acid (NEFA) availability as a result of acipimox supplementation worsened muscle insulin resistance without affecting amino acid kinetics, suggesting increased muscle NEFA uptake may contribute to inactivity-induced insulin resistance but does not cause anabolic resistance.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Resistencia a la Insulina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Am J Physiol Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Resistencia a la Insulina Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Am J Physiol Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido